We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.
UKHSA launches a call for evidence to shape England’s 2026 to 2031 TB Action Plan as TB rates continue to rise.
A new collaboration between The Pandemic Institute (TPI) and Dstl, is set to fund vital research into emerging infectious diseases.
In 2024, 904 dengue cases were reported in returning travellers across England, Wales and Northern Ireland, up from 631 in 2023.
New UKHSA study shows the RSV vaccination programme already achieving a 30% reduction in hospital admissions in older people in England as roll-out continues.
A new Priority Pathogens reference tool aims to support national funders of research and development into diagnostics, vaccines and therapeutics.
The UK Health Security Agency (UKHSA) latest updates on Clade Ib mpox.
From April 6, 2025, UKHSA requires medical professionals to report 8 more diseases, while labs must report 10 new pathogens to boost surveillance.
Latest data show continued progress towards elimination of hepatitis C as a public health threat in England
UKHSA is tracing contacts of a person who travelled to England with Lassa fever and has since returned to Nigeria, with overall public risk remaining very low.
The report finds that overall healthcare-associated infections were present in 7.6% of patients, a 1% increase on the last reported figures in 2016.
On HPV Awareness Day, parents are reminded HPV vaccine gives protection against cervical cancer and protects both girls and boys from several other types of cancer.
A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk of getting lower respiratory tract disease caused by RSV, compared with those who received placebo.
People who have already had the virus this winter could be at risk again, as new data shows shift in circulating strains.
Community testing in 2023, including nightclubs and festivals, rose by 7% compared to 2022.
Over 20,000 self-testing and self-sampling kits will be made available to help end HIV transmissions by the end of the decade.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness.
The UK launches mSCAPE, a world-first metagenomics initiative by UKHSA to enhance health security through rapid pathogen detection and surveillance.
UK TB cases rise 13% in 2024, continuing upward trend.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).